Mohammad Hossein Asgardoon Selected Research

Mohammad Hossein Asgardoon Research Topics

2	Inflammation (Inflammations) 01/2022 - 01/2019
2	Primary Immunodeficiency Diseases 01/2020 - 01/2015
2	Common Variable Immunodeficiency 01/2020 - 01/2016
1	COVID-19 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2022
1	Vision Disorders (Hemeralopia) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Malnutrition (Nutritional Deficiencies) 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Pain (Aches) 01/2022
1	Ischemia 10/2021
1	Ischemic Stroke 10/2021
1	Burns 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2020

2	Therapeutic UsesIBA 01/2022 - 10/2021
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 01/2015
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019 - 01/2016
1	Baclofen FDA LinkGeneric 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Clonidine (ST 155)FDA LinkGeneric 01/2022
1	Dapsone FDA Link 01/2022
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2022
1	Pregabalin (Lyrica)FDA Link 01/2022
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2022
1	Lamotrigine (Lamictal)FDA LinkGeneric 01/2022
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2022
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 01/2022
1	Tramadol (K315)FDA LinkGeneric 01/2022
1	Trazodone (Trittico)FDA LinkGeneric 01/2022
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2022
1	Alfentanil (Alfenta)FDA LinkGeneric 01/2022
1	Type A Botulinum Toxins (Botox)FDA Link 01/2022
1	Morphine (MS Contin)FDA LinkGeneric 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2021
1	Hematoxylin (Haematoxylon)IBA 10/2021
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	guluronic acidIBA 01/2019